CD2 Immunobiology

被引:97
作者
Binder, Christian [1 ,2 ]
Cvetkovski, Filip [2 ]
Sellberg, Felix [1 ,2 ]
Berg, Stefan [2 ]
Visbal, Horacio Paternina [1 ,2 ]
Sachs, David H. [2 ,3 ]
Berglund, Erik [2 ,4 ,5 ]
Berglund, David [1 ,2 ]
机构
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Sect Clin Immunol, Uppsala, Sweden
[2] ITB Med AB, Res & Dev, Stockholm, Sweden
[3] Columbia Univ, Dept Med, Columbia Ctr Translat Immunol, Med Ctr, New York, NY USA
[4] Karolinska Inst, Div Transplantat Surg, CLINTEC, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Transplantat Surg, Stockholm, Sweden
关键词
CD2; CD58; LFA-3 (lymphocyte functional antigen-3); T cell activation; costimulation; costimulation blockade; Alefacept; siplizumab; T-CELL-RECEPTOR; ANTI-CD2; MONOCLONAL-ANTIBODY; NATURAL-KILLER-CELLS; PLASMA-MEMBRANE MICRODOMAINS; BONE-MARROW-TRANSPLANTATION; ADHESION MOLECULE CD2; CYTOPLASMIC DOMAIN; THYMIC SELECTION; CAPPING PROTEIN; SAFETY PROFILE;
D O I
10.3389/fimmu.2020.01090
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The glycoprotein CD2 is a costimulatory receptor expressed mainly on T and NK cells that binds to LFA3, a cell surface protein expressed on e.g., antigen-presenting cells. CD2 has an important role in the formation and organization of the immunological synapse that is formed between T cells and antigen-presenting cells upon cell-cell conjugation and associated intracellular signaling. CD2 expression is upregulated on memory T cells as well as activated T cells and plays an important role in activation of memory T cells despite the coexistence of several other costimulatory pathways. Anti-CD2 monoclonal antibodies have been shown to induce immune modulatory effectsin vitroand clinical studies have proven the safety and efficacy of CD2-targeting biologics. Investigators have highlighted that the lack of attention to the CD2/LFA3 costimulatory pathway is amissed opportunity. Overall, CD2 is an attractive target for monoclonal antibodies intended for treatment of pathologies characterized by undesired T cell activation and offers an avenue to more selectively target memory T cells while favoring immune regulation.
引用
收藏
页数:14
相关论文
共 162 条
[1]   Safety Profile and Clinical Outcomes in a Phase I, Placebo-Controlled Study of Siplizumab in Acute Graft-Versus-Host Disease [J].
Adkins, Douglas ;
Ratanatharathorn, Voravit ;
Yang, Harry ;
White, Barbara .
TRANSPLANTATION, 2009, 88 (02) :198-202
[2]   Practical NK cell phenotyping and variability in healthy adults [J].
Angelo, Laura S. ;
Banerjee, Pinaki P. ;
Monaco-Shawver, Linda ;
Rosen, Joshua B. ;
Makedonas, George ;
Forbes, Lisa R. ;
Mace, Emily M. ;
Orange, Jordan S. .
IMMUNOLOGIC RESEARCH, 2015, 62 (03) :341-356
[3]   A SOLUBLE MULTIMERIC RECOMBINANT CD2 PROTEIN IDENTIFIES CD48 AS A LOW AFFINITY LIGAND FOR HUMAN CD2 - DIVERGENCE OF CD2 LIGANDS DURING THE EVOLUTION OF HUMANS AND MICE [J].
ARULANANDAM, ARN ;
MOINGEON, P ;
CONCINO, MF ;
RECNY, MA ;
KATO, K ;
YAGITA, H ;
KOYASU, S ;
REINHERZ, EL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) :1439-1450
[4]   The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse [J].
Badour, K ;
Zhang, JY ;
Shi, F ;
McGavin, MKH ;
Rampersad, V ;
Hardy, LA ;
Field, D ;
Siminovitch, KA .
IMMUNITY, 2003, 18 (01) :141-154
[5]   CD2 Costimulation Reveals Defective Activity by Human CD4+CD25hi Regulatory Cells in Patients with Multiple Sclerosis [J].
Baecher-Allan, Clare M. ;
Costantino, Cristina M. ;
Cvetanovich, Gregory L. ;
Ashley, Charles W. ;
Beriou, Gaelle ;
Dominguez-Villar, Margarita ;
Hafler, David A. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (06) :3317-3326
[6]   Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303 [J].
Bartlett, Nancy L. ;
Wilson, Wyndham H. ;
Jung, Sin-Ho ;
Hsi, Eric D. ;
Maurer, Matthew J. ;
Pederson, Levi D. ;
Polley, Mei-Yin C. ;
Pitcher, Brandelyn N. ;
Cheson, Bruce D. ;
Kahl, Brad S. ;
Friedberg, Jonathan W. ;
Staudt, Louis M. ;
Wagner-Johnston, Nina D. ;
Blum, Kristie A. ;
Abramson, Jeremy S. ;
Reddy, Nishitha M. ;
Winter, Jane N. ;
Chang, Julie E. ;
Gopal, Ajay K. ;
Chadburn, Amy ;
Mathew, Susan ;
Fisher, Richard I. ;
Richards, Kristy L. ;
Schoder, Heiko ;
Zelenetz, Andrew D. ;
Leonard, John P. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (21) :1790-+
[7]   The SH3 domain of p56(lck) binds to proline-rich sequences in the cytoplasmic domain of CD2 [J].
Bell, GM ;
Fargnoli, J ;
Bolen, JB ;
Kish, L ;
Imboden, JB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :169-178
[8]   Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques - an experimental study [J].
Berglund, Erik ;
Alonso-Guallart, Paula ;
Danton, Makenzie ;
Sellberg, Felix ;
Binder, Christian ;
Frobom, Robin ;
Berglund, David ;
Llore, Nathaly ;
Sakai, Hiroshi ;
Iuga, Alina ;
Ekanayake-Alper, Dilrukshi ;
Reimann, Keith A. ;
Sachs, David H. ;
Sykes, Megan ;
Griesemer, Adam .
TRANSPLANT INTERNATIONAL, 2020, 33 (01) :98-107
[9]   NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs [J].
Beziat, Vivien ;
Liu, Lisa L. ;
Malmberg, Jenny-Ann ;
Ivarsson, Martin A. ;
Sohlberg, Ebba ;
Bjorklund, Andreas T. ;
Retiere, Christelle ;
Sverremark-Ekstrom, Eva ;
Traherne, James ;
Ljungman, Per ;
Schaffer, Marie ;
Price, David A. ;
Trowsdale, John ;
Michaelsson, Jakob ;
Ljunggren, Hans-Gustaf ;
Malmberg, Karl-Johan .
BLOOD, 2013, 121 (14) :2678-2688
[10]   CRYSTAL-STRUCTURE OF THE EXTRACELLULAR REGION OF THE HUMAN CELL-ADHESION MOLECULE CD2 AT 2.5-ANGSTROM RESOLUTION [J].
BODIAN, DL ;
JONES, EY ;
HARLOS, K ;
STUART, DI ;
DAVIS, SJ .
STRUCTURE, 1994, 2 (08) :755-766